• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

InSynQ清单的制定:一种用于在干预措施系统评价中规划和报告综合问题的工具。

Development of the InSynQ checklist: A tool for planning and reporting the synthesis questions in systematic reviews of interventions.

作者信息

Cumpston Miranda S, McKenzie Joanne E, Ryan Rebecca, Flemyng Ella, Thomas James, Brennan Sue E

机构信息

Methods in Evidence Synthesis Unit, School of Public Health and Preventive Medicine Monash University Melbourne Victoria Australia.

Centre for Health Communication and Participation La Trobe University Melbourne Victoria Australia.

出版信息

Cochrane Evid Synth Methods. 2023 Dec 12;1(10):e12036. doi: 10.1002/cesm.12036. eCollection 2023 Dec.

DOI:10.1002/cesm.12036
PMID:40476007
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11795942/
Abstract

INTRODUCTION

Methods guidance and appraisal tools for systematic reviews require specification of the question and eligibility criteria for the review ("PICO for the review"). Less emphasis has been given to specifying the question and criteria for each synthesis ("PICO for each synthesis"), yet decisions about which studies to include in each synthesis can critically influence the utility and findings of a review. This paper describes the rationale and methods for developing the InSynQ (Intervention Synthesis Questions) tool for planning and reporting synthesis questions in reviews of interventions. The aim is to provide transparency about the basis of the tool and contribute to evidence on methods for developing guidance for research conduct and reporting.

METHODS

Informed by EQUATOR Network methods, we (1) established a project group; (2) examined reporting of the "PICO for each synthesis" in published reviews; (3) reviewed existing reporting guidance and the ; (4) drafted items with elaboration, explanation, and examples; (5) conducted consultation meetings, an evaluation survey and pilot test; (6) incorporated feedback.

RESULTS

Existing reporting guidelines do not distinguish the review and synthesis PICO, with limited coverage of the elements needed to specify the PICO for each synthesis. Using the PRISMA 2020 format, the draft tool contained 10 items with essential and additional reporting elements, explanations, and examples. Revisions arising from consultation meetings (>30 people), included adding an eleventh item on consumer and stakeholder involvement, a figure explaining PICO for each synthesis, and integrating examples into elements/explanations. All respondents to the survey (12 people) said the tool would help them plan or appraise synthesis questions. InSynQ is available at https://InSynQ.info.

CONCLUSION

Transparent reporting of the development process contributes to the evidence base for methods to develop guidance. It may improve uptake of InSynQ, in turn enhancing the clarity of syntheses.

摘要

引言

系统评价的方法指南和评估工具要求明确评价的问题和纳入标准(“评价的PICO”)。对于明确每次综合分析的问题和标准(“每次综合分析的PICO”)的重视程度较低,然而关于每次综合分析纳入哪些研究的决策可能会严重影响评价的效用和结果。本文描述了开发InSynQ(干预综合分析问题)工具的基本原理和方法,该工具用于在干预评价中规划和报告综合分析问题。目的是提高该工具基础的透明度,并为制定研究实施和报告指南的方法提供证据。

方法

以EQUATOR网络方法为依据,我们(1)成立了一个项目组;(2)检查已发表评价中“每次综合分析的PICO”的报告情况;(3)审查现有的报告指南;(4)起草带有详细说明、解释和示例的条目;(5)召开咨询会议、进行评估调查和预试验;(6)纳入反馈意见。

结果

现有的报告指南没有区分评价和综合分析的PICO,对明确每次综合分析的PICO所需要素的涵盖有限。使用PRISMA 2020格式,该工具草案包含10个条目,以及基本和额外报告要素、解释和示例。咨询会议(30多人)产生的修订包括增加关于消费者和利益相关者参与的第11个条目、一个解释每次综合分析PICO的图表,并将示例纳入要素/解释中。调查的所有受访者(12人)表示,该工具将帮助他们规划或评估综合分析问题。InSynQ可在https://InSynQ.info上获取。

结论

开发过程的透明报告有助于为制定指南的方法提供证据基础。这可能会提高InSynQ的采用率,进而提高综合分析的清晰度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e57b/11795942/30f5e3822df1/CESM-1-e12036-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e57b/11795942/30f5e3822df1/CESM-1-e12036-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e57b/11795942/30f5e3822df1/CESM-1-e12036-g001.jpg

相似文献

1
Development of the InSynQ checklist: A tool for planning and reporting the synthesis questions in systematic reviews of interventions.InSynQ清单的制定:一种用于在干预措施系统评价中规划和报告综合问题的工具。
Cochrane Evid Synth Methods. 2023 Dec 12;1(10):e12036. doi: 10.1002/cesm.12036. eCollection 2023 Dec.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
4
Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024.报告结局测量工具(OMIs)系统评价的指南:PRISMA-COSMIN 2024 年 OMIs 版。
J Clin Epidemiol. 2024 Sep;173:111422. doi: 10.1016/j.jclinepi.2024.111422. Epub 2024 Jul 9.
5
The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.综合护理路径在医疗环境中对成人和儿童的有效性:一项系统评价。
JBI Libr Syst Rev. 2009;7(3):80-129. doi: 10.11124/01938924-200907030-00001.
6
Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024.系统评价报告结局测量工具(OMIs)的指南:PRISMA-COSMIN 对 OMIs 的 2024 年修订版。
Health Qual Life Outcomes. 2024 Jul 9;22(1):48. doi: 10.1186/s12955-024-02256-9.
7
Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024.报告结局测量工具(OMIs)系统评价的指南:2024 年 OMIs 的 PRISMA-COSMIN。
J Patient Rep Outcomes. 2024 Jul 9;8(1):64. doi: 10.1186/s41687-024-00727-7.
8
Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024.报告结局测量工具(OMIs)系统评价的指南:PRISMA-COSMIN 2024 版。
Qual Life Res. 2024 Aug;33(8):2029-2046. doi: 10.1007/s11136-024-03634-y. Epub 2024 Jul 9.
9
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.超越黑木树:影响澳大利亚地区、农村和偏远地区的健康研究问题的快速综述。
Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881.
10
Reporting items for systematic reviews and meta-analyses of acupuncture: the PRISMA for acupuncture checklist.针灸系统评价和荟萃分析报告条目:针灸 PRISMA 清单。
BMC Complement Altern Med. 2019 Aug 12;19(1):208. doi: 10.1186/s12906-019-2624-3.

本文引用的文献

1
Critical elements of synthesis questions are incompletely reported: survey of systematic reviews of intervention effects.综合问题的关键要素报告不完整:干预效果系统评价的调查
J Clin Epidemiol. 2023 Nov;163:79-91. doi: 10.1016/j.jclinepi.2023.09.013. Epub 2023 Sep 29.
2
Evaluating medical tests: introducing the Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy.评估医学检验:介绍《Cochrane诊断试验准确性系统评价手册》
Cochrane Database Syst Rev. 2023 Jul 20;7(7):ED000163. doi: 10.1002/14651858.ED000163.
3
Reporting guidelines used varying methodology to develop recommendations.
报告指南使用了不同的方法来制定建议。
J Clin Epidemiol. 2023 Jul;159:246-256. doi: 10.1016/j.jclinepi.2023.03.018. Epub 2023 Mar 24.
4
Reporting guideline for overviews of reviews of healthcare interventions: development of the PRIOR statement.医疗干预措施系统评价概述报告规范:PRIOR 声明的制定。
BMJ. 2022 Aug 9;378:e070849. doi: 10.1136/bmj-2022-070849.
5
Vaccines for preventing rotavirus diarrhoea: vaccines in use.轮状病毒疫苗预防腹泻:正在使用的疫苗。
Cochrane Database Syst Rev. 2021 Nov 17;11(11):CD008521. doi: 10.1002/14651858.CD008521.pub6.
6
Non-pharmacological measures implemented in the setting of long-term care facilities to prevent SARS-CoV-2 infections and their consequences: a rapid review.长期护理机构中实施的非药物措施以预防 SARS-CoV-2 感染及其后果:快速综述。
Cochrane Database Syst Rev. 2021 Sep 15;9(9):CD015085. doi: 10.1002/14651858.CD015085.pub2.
7
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
8
PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews.PRISMA 2020 解释和说明:系统评价报告的更新指南和范例。
BMJ. 2021 Mar 29;372:n160. doi: 10.1136/bmj.n160.
9
Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline.系统评价中不进行荟萃分析的综合 (SWiM):报告指南。
BMJ. 2020 Jan 16;368:l6890. doi: 10.1136/bmj.l6890.
10
Identifying the PECO: A framework for formulating good questions to explore the association of environmental and other exposures with health outcomes.确定PECO:一个用于提出好问题以探究环境及其他暴露因素与健康结果之间关联的框架。
Environ Int. 2018 Dec;121(Pt 1):1027-1031. doi: 10.1016/j.envint.2018.07.015. Epub 2018 Aug 27.